abstract |
The invention provides a method of treating cognitive or neurodegenerative diseases, which method comprises administering to a patient in need of such treatment an effective amount of a compound of formula I: , Or a pharmaceutically acceptable salt thereof, in combination with an effective amount of an anti-N3pGlu Aβ antibody, the antibody is selected from the group consisting of: hE8L, B12L, R17L, antibody I and antibody II. |